December 1, 2015
The Perils Of A Big Pharma Partnership
– What a Megamerger Like Pfizer and Allergan’s Can Mean to Biotech Partnerships – The media commentary around Pfizer and Allergan’s mega merger announced earlier this week has focused primarily around the fact that the deal is structured as a corporate inversion so that Pfizer can reduce its expected tax rate from 25% to 17%. While investors are sweating over whether the US government will...
October 13, 2015
Bellus Health’s Shiga Toxin Antibody ShigamabTM
– Highlighted at the VTEC 2015 Conference – The triennial International Symposium on Shiga Toxin (Verocytotoxin)-producing Escherichia coli (the VTEC Conference) was held in Boston from September 13th to 16th, 2015. Approximately 300 researchers in epidemiology, infectious diseases, microbiology, immunology, veterinary sciences, pediatric nephrology and gastroenterology shared their latest...